Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

News and Events

NewsEvents

IP in the digital age: a tricky path ahead for pharma companies

Date: 20 September 2016

James Cross, Partner at Maucher Jenkins, has contributed to an article published by Life Sciences Intellectual Property Review concerning IP protection in the world of digital health and the need for pharmaceutical companies to adjust in the digital age.

 

You can read the full article from LSIPR by clicking here

To ensure we give you the best experience on our website we use Cookies. You can change your cookie settings at any time. However, if you continue without changing your settings we will presume you are happy to receive all cookies on the Maucher Jenkins website.

Continue